Providing digital security of healthcare system with criminal-legal means

Objective : to develop a comprehensive system of ethical principles for the formation of a regulatory framework and the practical implementation of digital bioprinting technologies in clinical practice. Methods : the research is based on the application of general scientific methods of scientific cognition (analysis, synthesis, induction, deduction, systematic approach), as well as private scientific methods of scientific cognition, including the logical and legal method. Results : the ethical and legal issues of 3D (three-dimensional) bioprinting as a developing field of high-tech medical care have not yet been widely discussed among specialists dealing with bioethics issues. The field of 3D bioprinting includes not only advanced technologies for printing human tissues and organs, but also raises a whole range of interdisciplinary scientific issues. The digital transformation of the healthcare system will inevitably entail an improvement in the regulatory regulation of bioprinting technologies, however, given the certain stability of the law, this will take a significant amount of time. Scientific novelty : a system of ethical principles has been developed that can form the basis of the law-making process of this digital technology and its practical implementation in clinical medicine. The ethical principles outlined by us in a systematic form can serve as the basis for the development and implementation of domestic legal regulation of bioprinting technologies. Based on the formulated ethical principles, it is possible to consider specific measures to improve domestic legislation and, in general, prevent potential negative consequences resulting from their application, which will allow technology to develop and will not be considered as an attempt by the state to establish control over it. Practical significance : the research results, including theoretical provisions, practical recommendations and conclusions, can be effectively used to form a legal environment for bioprinting technologies, develop scientific research at the intersection of medicine, digital technologies and fundamental science, and improve the regulatory framework in the field of high-tech medical care.